Research and Markets: Essential New Report: Pharmaceutical Pricing and Reimbursement in India
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/20aa52/pharmaceutical_pri) has announced the addition of Decision Resources, Inc.'s new report "Pharmaceutical Pricing and Reimbursement in India" to their offering. Faced with a dramatic slowdown in sales in mature pharmaceutical markets, multinational pharmaceutical companies are looking to substantially increase their sales in India and other emerging markets. The Indian market is growing by more than 10% per year, but foreign companies will need to overcome significant obstacles to succeed in a market currently dominated by domestic manufacturers. Questions Answered in This Report The Indian population is forecast to grow from its present size of 1.2 billion to 1.7 billion in 2050. * How will the age breakdown of the population evolve over time? * How will the balance between India's urban and rural populations change in the coming years? Only a minority of Indians have health insurance. * What are the main forms of health insurance? * How do most Indians fund healthcare and medications? The Indian government controls the prices of 74 scheduled medicines. * Which agents are subject to price control? * How are prices of other drugs regulated? * How does the government penalize overcharging for drugs? * How do prices in India compare with prices in other markets? * What pricing reforms is the Indian government contemplating? Scope * Demographic trends: population breakdown by age and sex; population breakdown by geographic distribution. * Organization and funding of healthcare: overview of the Indian healthcare system; access to healthcare; health insurance; out-of-pocket expenditures. * Pharmaceutical pricing: historical price controls; current price control system; price adjustments; penalties for overcharging for drugs; international price comparison; multinational companies' pricing strategies. * Outlook and implications for the pharmaceutical industry: encouraging commercial outlook; potential government reforms; opportunities and threats for multinationals. Key Topics Covered: Executive Summary Overview Demographic Trends Organization and Funding of Healthcare Pharmaceutical Market Trends Intellectual Property Rights Regulation of the Indian Pharmaceutical Market Pharmaceutical Pricing Distribution Challenges Measures to Promote Greater Use of Inexpensive Generics Outlook and Implications for the Pharmaceutical Industry For the complete list of over 50 companies that feature in this report, click the link below http://www.researchandmarkets.com/research/20aa52/pharmaceutical_pri Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Copyright Business Wire 2009
